Why I'm Continuing To Hold Johnson & Johnson

When a stock sits at an all time high share price, some investors tend to become nervous. Although shareholders focused on dividends (and dividend growth) are often more patient than most other investors, a slightly elevated valuation can still lead to stress. Johnson & Johnson (NYSE:JNJ) shares currently sit at an all time high, and, like most of the S&P 500, trade at an above average earnings multiple.

As a Johnson & Johnson shareholder, I'm looking to achieve 8-10% in capital appreciation, plus a 2-3% dividend each year for a total return of 10-12%. If your return expectations are significantly higher than this, you might end up disappointed (if this is the case, I'd love to know what investments make up your portfolio).

This article takes a long term approach (30 months). Using analyst earnings expectations and historical earnings multiples for J&J shares, it is fairly easy to find a range of potential returns for shareholders of this dividend aristocrat over this time period.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.